Amy Thomson

Amy Thomson is a pioneering entrepreneur and women's health innovator who helps organisations understand how technology, data and hormonal wellbeing intersect to unlock performance and empower communities. She founded Moody Month, an AI-powered app supporting over 100,000 women worldwide with personalised hormone insights, and previously built and successfully exited Seen, a brand measurement platform trusted by Nike and LVMH. Amy has raised over $4 million in funding and scaled ventures to multi-million-dollar revenues. Her sessions equip audiences with practical strategies for leveraging AI in healthcare, building agile businesses, and championing inclusive innovation that drives real-world impact.

When Amy Thomson founded Moody Month, she set out to solve a problem that affects half the world's population yet remains largely overlooked by mainstream technology: helping women understand their hormones. The app she built now supports over 100,000 users globally, using advanced machine learning to deliver personalised insights that empower women to track their cycles, manage symptoms, and take control of their wellbeing. Before launching Moody Month, Amy founded Seen, a brand measurement platform that redefined how companies like Nike and LVMH understood their market value, a venture she successfully scaled and sold before turning her attention to women's health innovation.

Amy's credibility stems from her dual expertise in technology and entrepreneurship, underpinned by a track record of building businesses that deliver measurable impact. She has raised more than $4 million in funding, navigated the challenges of scaling agile ventures, and grown companies from early-stage concepts to multi-million-dollar revenues. Her work sits at the intersection of artificial intelligence, healthcare, and data science, areas where she has developed a deep understanding of how emerging technologies can be harnessed to address real-world challenges. Amy's focus on women's health is informed not only by her entrepreneurial journey but also by her commitment to destigmatising periods, promoting self-care, and making complex science accessible to everyday users. Her insights into the role of hormones in mental and physical wellbeing, combined with her experience in digital health innovation, position her as a trusted voice in a rapidly evolving sector.

Amy equips audiences with practical strategies they can apply immediately, whether they are navigating the digital transformation of healthcare, building inclusive products, or leading innovation in traditionally underserved markets. Her sessions explore how AI and data can unlock performance, improve decision-making, and drive meaningful change within organisations and communities. She speaks with clarity and energy, translating technical concepts into actionable insights that resonate across industries. Audiences leave her talks with a deeper understanding of how technology can be used responsibly and creatively to solve pressing problems, along with the confidence to champion innovation that delivers lasting impact. Amy's ability to connect entrepreneurial thinking with mission-driven purpose ensures her presentations inspire action, foster resilience, and empower leaders to build businesses and cultures that prioritise both performance and wellbeing.